Potential biomarkers may predict response to TKIs in metastatic kidney cancer
A recent study published in Clinical Cancer Research and conducted in [...]
Treatment of renal cell carcinoma
The following series of interviews with the world's leading kidney [...]
Effect of antibiotics on targeted therapy and immunotherapy for kidney cancer
The following is an interview with Dr Neeraj Agarwal, Associate [...]
Sequencing of treatments for advanced kidney cancer remains uncertain
There are now a number of licensed drug options available [...]
Type of long-term response to targeted therapy affects outcomes for advanced kidney cancer
A retrospective study conducted by researchers in the Czech Republic [...]
Novel treatment options for kidney cancer presented at ASCO 2017
The following video is an interview between PracticeUpdate and Dr Bradley [...]
Nivolumab and cabozantinib accepted for use within NHS Scotland for advanced kidney cancer
The Scottish Medicines Consortium (SMC), which reviews newly licensed medicines, [...]
Aflibercept shows promise in second-line treatment of advanced kidney cancer
A study reported in the online PracticeUpdate journal Renal Cell [...]
Adjuvant therapy for high-risk localised kidney cancer
This literature review was published in The Journal of Urology [...]
Immunotherapy combined with VEGF inhibitors for kidney cancer
In this video interview, Dr Shilpa Gupta, assistant professor, Haematology, [...]
